Evidence map›Paper›PMID 34428950›Full record

ArticleJournal of the Royal Society, Interface2021

A data driven agent-based model that recommends non-pharmaceutical interventions to suppress Coronavirus disease 2019 resurgence in megacities.

Ling Yin, Hao Zhang, Yuan Li, Kang Liu, Tianmu Chen, Wei Luo, Shengjie Lai, Ye Li, Xiujuan Tang, Li Ning and 6 more

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Who Gets the Flu? Individualized Validation of Influenza-like Illness in Urban Spaces.International journal of environmental research and public health · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ling YinShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, People's Republic of China.
Hao ZhangShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, People's Republic of China.
Yuan LiShenzhen Center for Disease Control and Prevention, Shenzhen 518055, Guangdong, People's Republic of China.
Kang LiuShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, People's Republic of China.
Tianmu ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, Fujian, People's Republic of China.
Wei LuoGeography Department, National University of Singapore, AS2-03-01, 1 Arts Link, Singapore 117570, Republic of Singapore.
Shengjie LaiWorldPop, School of Geography and Environmental Science, University of Southampton, Southampton SO17 1BJ, UK.
Ye LiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, People's Republic of China.
Xiujuan TangShenzhen Center for Disease Control and Prevention, Shenzhen 518055, Guangdong, People's Republic of China.
Li NingShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, People's Republic of China.
Shengzhong FengNational Supercomputing Center in Shenzhen, Shenzhen 518055, Guangdong, People's Republic of China.
Yanjie WeiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, People's Republic of China.
Zhiyuan ZhaoThe Academy of Digital China (Fujian), Fuzhou University, Fuzhou 350108, Fujian, People's Republic of China.
Ying WenShenzhen Center for Disease Control and Prevention, Shenzhen 518055, Guangdong, People's Republic of China.
Liang MaoDepartment of Geography, University of Florida, Gainesville, FL 32611, USA.
Shujiang MeiShenzhen Center for Disease Control and Prevention, Shenzhen 518055, Guangdong, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Before herd immunity against Coronavirus disease 2019 (COVID-19) is achieved by mass vaccination, science-based guidelines for non-pharmaceutical interventions are urgently needed to reopen megacities. This study integrated massive mobile phone tracking records, census data and building characteristics into a spatially explicit agent-based model to simulate COVID-19 spread among 11.2 million individuals living in Shenzhen City, China. After validation by local epidemiological observations, the model was used to assess the probability of COVID-19 resurgence if sporadic cases occurred in a fully reopened city. Combined scenarios of three critical non-pharmaceutical interventions (contact tracing, mask wearing and prompt testing) were assessed at various levels of public compliance. Our results show a greater than 50% chance of disease resurgence if the city reopened without contact tracing. However, tracing household contacts, in combination with mandatory mask use and prompt testing, could suppress the probability of resurgence under 5% within four weeks. If household contact tracing could be expanded to work/class group members, the COVID resurgence could be avoided if 80% of the population wear facemasks and 40% comply with prompt testing. Our assessment, including modelling for different scenarios, helps public health practitioners tailor interventions within Shenzhen City and other world megacities under a variety of suppression timelines, risk tolerance, healthcare capacity and public compliance.

Indexed as

Models, TheoreticalChinaCitiesCommunicable Disease ControlContact TracingCOVID-19COVID-19 TestingHumansImmunity, HerdMasksagent-based modelcontact tracingCOVID-19facemaskmobile phone datatesting

Identifiers

PMID34428950
PMCPMC8385367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.